| Kendra Wheeler, | |
|
101 Progress Dr, Doylestown, PA 18901-2563 | |
| (215) 622-5004 | |
| Not Available |
| Full Name | Kendra Wheeler |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 101 Progress Dr, Doylestown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003262841 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL007365 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kendra Wheeler, 131 Bates Dr, Chalfont, PA 18914-2401 Ph: (215) 822-6425 | Kendra Wheeler, 101 Progress Dr, Doylestown, PA 18901-2563 Ph: (215) 622-5004 |
News Archive
Alan W. Heldman, M.D., of the University of Miami Miller School of Medicine, and colleagues conducted a study to examine the safety of transendocardial stem cell injection with autologous mesenchymal stem cells and bone marrow mononuclear cells in patients with ischemic cardiomyopathy.
Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy.
Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced that new data highlighting fidaxomicin's (OPT-80) lower CDI recurrence rates and reduced risk of vancomycin-resistant enterococci (VRE) acquisition from Optimer's North American phase 3 study were presented at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco.
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Biologists from Austria and Singapore developed a technique that adds a new twist on the relationship between biology and art. In an article recently published online in The FASEB Journal and scheduled for the August 2008 print issue, these researchers describe how they were able to coat-or paint-viruses with proteins.
› Verified 8 days ago
Mr. Charles William Belt, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 South Main Street, Suite 315, Doylestown, PA 18901 Phone: 215-489-8760 Fax: 215-489-8766 | |
Mr. Phillip A Hernandez Jr., MS CCCSLPL Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 South Main Street, Suite 315, Doylestown, PA 18901 Phone: 215-489-8760 Fax: 215-489-8766 | |
Stefanie Brown, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 705 N Shady Retreat Rd, Doylestown, PA 18901 Phone: 800-770-4822 | |
Rachel Friel, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 739 N Easton Rd Ste 202, Doylestown, PA 18902 Phone: 215-345-5960 | |
Morley K Ewing, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 Short Road, Doylestown, PA 18901 Phone: 215-340-9869 | |
Julianna Magazzeni, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 777 Ferry Rd, Doylestown, PA 18901 Phone: 215-340-5228 |